Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06107335 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Albumin Versus Routine Care on Hemodynamic Response and Stability in Patients With Preeclampsia Guided by a Non-invasive Hemodynamic Monitoring System During Cesarean Delivery With Spinal Anesthesia

StatusNot Yet Recruiting
PhasePhase 4
Started2025-07-01
View on ClinicalTrials.gov ↗

Amendment history

2024-12-04
Study Status v3
Primary completion date2024-12-01→2026-12-01
Completion date2025-07-01→2026-12-01
Start date2024-07-01→2025-07-01
2024-05-07
Study Status v2
Primary completion date2024-05-01→2024-12-01
Completion date2024-11-01→2025-07-01
Start date2023-12-30→2024-07-01
2023-12-01
Study Status v1
Start date2023-11-01→2023-12-30
2023-10-24
Original filing
The purpose of this study is to compare the effect of albumin versus routine care on hemodynamic response and stability in pre-eclamptic patients during cesarean delivery. The hypothesis is that volume replacement with albumin guided by stroke volume variation (SVV) using a ClearSight-Acumen (CS-A) monitor, before cesarean delivery (CD), improves hemodynamic stability in preeclamptic patients with severe features compared to routine care, under neuraxial anesthesia.
Trial Details
NCT Number NCT06107335
Lead Sponsor The University of Texas Health Science Center, Houston
Conditions Pre-Eclampsia
Enrollment 62 participants
Start Date 2025-07-01
Primary Completion 2026-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2024-12-06